Ayala Pharmaceuticals (ADXS) SEC Filings & 10K Form

$0.03 0.00 (0.00%)

(As of 12/20/2024 03:31 PM ET)

Compare

Recent Ayala Pharmaceuticals SEC Filings

Filing Types

Ownership Filings

Time Frame

Start Date

End Date

Export to Excel

Date	Filer	Form Type
04/19/2024 6:50 AM	Ayala Pharmaceuticals (Filer)	Form 8-K/A
04/16/2024 3:11 PM	Ayala Pharmaceuticals (Filer)	Form 10-K Annual report pursuant to Section 13 or 15(d)
04/15/2024 3:33 PM	Ayala Pharmaceuticals (Filer)	Form S-8 POS
04/15/2024 3:33 PM	Ayala Pharmaceuticals (Filer)	Form S-8 POS
04/15/2024 3:34 PM	Ayala Pharmaceuticals (Filer)	Form S-8 POS
04/15/2024 3:34 PM	Ayala Pharmaceuticals (Filer)	Form S-8 POS
04/15/2024 3:30 PM	Ayala Pharmaceuticals (Filer)	Form S-8 POS
04/15/2024 3:31 PM	Ayala Pharmaceuticals (Filer)	Form S-8 POS
04/15/2024 3:31 PM	Ayala Pharmaceuticals (Filer)	Form S-8 POS
04/15/2024 3:32 PM	Ayala Pharmaceuticals (Filer)	Form S-8 POS
04/15/2024 3:32 PM	Ayala Pharmaceuticals (Filer)	Form S-8 POS
04/03/2024 4:01 PM	Ayala Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
04/01/2024 3:31 PM	Ayala Pharmaceuticals (Filer)	Form NT 10-K
03/29/2024 4:06 PM	Ayala Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
03/06/2024 6:13 AM	Ayala Pharmaceuticals (Issuer) I.B.F. Management Ltd. (Reporting) Israel Biotech Fund GP Partners II, L.P. (Reporting) Israel Biotech Fund GP Partners, L.P. (Reporting) Israel Biotech Fund I, L.P. (Reporting) Israel Biotech Fund II, L.P. (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
03/05/2024 7:16 AM	Ayala Pharmaceuticals (Filer)	Form DEFM14C
02/20/2024 4:22 PM	Ayala Pharmaceuticals (Filer)	Form PREM14C
02/12/2024 1:16 PM	Ayala Pharmaceuticals (Issuer) I.B.F. Management Ltd. (Reporting) Israel Biotech Fund GP Partners II, L.P. (Reporting) Israel Biotech Fund GP Partners, L.P. (Reporting) Israel Biotech Fund I, L.P. (Reporting) Israel Biotech Fund II, L.P. (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
02/12/2024 10:58 AM	Ayala Pharmaceuticals (Subject) Israel Biotech Fund I, L.P. (Filed by)	Form SC 13D/A
02/12/2024 7:27 AM	Ayala Pharmaceuticals (Subject) Schindel Yair Chaim (Filed by)	Form SC 13G/A
02/09/2024 4:15 PM	Ayala Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
02/06/2024 7:51 AM	Ayala Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)

(Data available from 1/1/2016 forward)

Related Companies and Tools

Related Companies

SEC Filings Tools

This page (NASDAQ:ADXS) was last updated on 12/22/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ayala Pharmaceuticals (ADXS) SEC Filings & 10K Form

Recent Ayala Pharmaceuticals SEC Filings

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ayala Pharmaceuticals (ADXS) SEC Filings & 10K Form

Recent Ayala Pharmaceuticals SEC Filings

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools